Company Biotech Development Srl with Fiscal Code 34633481
recorded a turnover of 2024 of
33.028,
with a net profit of
4.163
and having an average number of employees of
1.
The company operates in the field of Alte activitati profesionale, stiintifice si tehnice n.c.a. having the NACE code 7490.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Biotech Development Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
85
11.918
30.950
24.962
46.977
38.658
34.097
26.878
30.782
33.028
Total Income - EUR
85
11.918
30.950
24.978
46.977
38.658
34.106
26.878
30.782
33.028
Total Expenses - EUR
50
524
569
1.917
20.461
16.285
22.032
13.776
24.509
28.541
Gross Profit/Loss - EUR
35
11.393
30.381
23.061
26.516
22.372
12.074
13.103
6.273
4.487
Net Profit/Loss - EUR
29
11.274
30.076
22.809
26.046
21.554
11.739
12.866
5.980
4.163
Employees
0
0
0
0
1
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 7.9%, from 30.782 euro in the year 2023, to 33.028 euro in 2024.
The Net Profit decreased by -1.783 euro, from 5.980 euro in 2023, to 4.163 in the last year.
Check the financial reports for the company - Biotech Development Srl
Financial Rating - BIOTECH DEVELOPMENT SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Biotech Development Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Biotech Development Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Biotech Development Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Biotech Development Srl - CUI 34633481
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
0
0
1.605
1.146
702
281
25
0
16
6
Current Assets
80
11.473
42.056
63.707
94.359
113.239
113.781
128.085
132.930
135.016
Inventories
0
0
0
0
0
0
0
0
0
1
Receivables
63
6.888
11.821
11.657
38.326
64.455
100.722
117.644
126.877
125.442
Cash
17
4.584
30.234
52.049
56.032
48.784
13.059
10.441
6.037
9.557
Shareholders Funds
74
11.348
41.232
63.284
88.104
107.988
112.115
125.330
130.930
134.361
Social Capital
45
45
0
43
42
41
40
41
40
40
Debts
6
125
2.429
1.568
6.957
5.532
1.691
2.755
2.016
661
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"7490 - 7490"
CAEN Financial Year
6311
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
135.016 euro in 2024 which includes Inventories of
1 euro, Receivables of
125.442 euro and cash availability of
9.557 euro.
The company's Equity was valued at
134.361 euro, while total Liabilities amounted to
661 euro.
Equity increased by 4.163 euro, from 130.930 euro in 2023, to 134.361 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Biotech Development Srl